Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early and Long-Term Health Outcomes of Molecular Cerebral Imaging in Incipient Dementia (MCI-ID) II

NCT02317250 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT02317250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02317250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early and Long-Term Health Outcomes of Molecular Cerebral Imaging in Incipient Dementia (MCI-ID) II
Lead sponsor
University of California, Los Angeles
Phase
Phase 3
Overall status
Withdrawn
Start date
June 30, 2018
Completion date
December 31, 2022
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment